Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Corrected VA With Long-Term Follow-Up After AcrySof® IOL Implantation

NCT02450799 is registered in ClinicalTrials.gov with Alcon, a Novartis Company as lead sponsor.

NCT NCT02450799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02450799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Corrected VA With Long-Term Follow-Up After AcrySof® IOL Implantation
Lead sponsor
Alcon, a Novartis Company
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2015
Completion date
May 31, 2016
Enrollment
104 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pseudophakia